Mary Beth Harler Igm Biosciences, Inc. (IGMS) insider trading activity

IGMS Quotes by TradingView

Mary Beth Harler is Head, Research & Autoimmunity of IGM Biosciences, Inc.. Currently has a direct ownership of 163,740 shares of IGMS, which is worth approximately $2.73 Million. The most recent transaction as insider was on Sep 13, 2024, when has been sold 1,487 shares (Common Stock) at a price of $11.54 per share, resulting in proceeds of $17,159. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 164K
92.12% 3M change
n/a 12M change
Total Value Held $2.73 Million

Mary Beth Harler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 13 2024
SELL
Open market or private sale
$17,159 $11.54 p/Share
1,487 Reduced 0.9%
163,740 Common Stock
Jul 19 2024
BUY
Grant, award, or other acquisition
-
80,000 Added 32.62%
165,227 Common Stock
Jun 14 2024
SELL
Open market or private sale
$11,900 $7.58 p/Share
1,570 Reduced 1.81%
85,227 Common Stock
MBH

Mary Beth Harler

Head, Research & Autoimmunity
Mountain View, CA

Track Institutional and Insider Activities on IGMS

Follow IGM Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IGMS shares.

Notify only if

Insider Trading

Get notified when an Igm Biosciences, Inc. insider buys or sells IGMS shares.

Notify only if

News

Receive news related to IGM Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IGMS